Navigation Links
CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
Date:9/11/2007

SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it has been invited to participate in a Food and Drug Administration (FDA) panel meeting to be held on September 20, 2007 from 8:00 am to 6:00 pm ET in Gaithersburg, Maryland. The FDA panel committee will discuss and make recommendations regarding clinical trial designs for cardiac ablation devices designed to treat patients with medically refractory atrial fibrillation.

Helen Barold, M.D., Chief Medical Officer of CryoCor, said, "We look forward to adding our experience to this general panel discussion on clinical trials for atrial fibrillation ablation."

About CryoCor

CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoablation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved for the treatment of right atrial flutter. For more information please visit the Company's website at http://www.cryocor.com.

Forward Looking Statements

The statements in this press release that are not descriptions of historical facts are forward-looking statements that are subject to risks and uncertainties. The actual events or results
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
2. AIDS Organization Invited To UN Special Session By S.A
3. Indian Boy Invited to Tie Turbans for a Wedding in Mauritius
4. NRIs Called Upon To Participate In AIDS Awareness Programs
5. Barbers In Malda Participate In HIV/AIDS Awareness Program
6. Corporate Groups To Participate In Jharkhand Health Care Scheme
7. Tallest man to participate in the Guinness day celebrations
8. Bengal Teenager to Participate in World Oncology Camp
9. Emory Participates in Study to Slow Progression of Parkinsons Disease
10. WHO lifts HongKong advisory
11. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Today, Good Neighbor Pharmacy ... patient care by kicking off another year of ... first of many education sessions and initiatives took ... Good Neighbor Pharmacy and AmerisourceBergen’s annual conference. Sessions ... (CMS) Star Measures were a highlight and helped ...
(Date:7/31/2014)... Denver, CO (PRWEB) July 31, 2014 ... Mexico vs. Bolivia tickets at Dick’s Sporting Goods Park ... several years, the Mexican national soccer team has found a ... successes and failures during their time playing international friendly games ... play Bolivia at Dick’s Sporting Goods Park in Commerce City, ...
(Date:7/31/2014)... HealthDay Reporter , THURSDAY, July 31, 2014 ... TVs or cigarettes, but people of ancient times commonly developed ... on some reasons why. Using CT scans of mummified ... American Southwest, researchers have found evidence of widespread atherosclerosis -- ... up, eventually leading to heart attack or stroke. That,s ...
(Date:7/31/2014)... Ottawa, Ontario (PRWEB) July 31, 2014 ... s deliver fitness to your home, which now includes ... certified personal trainers have been delivering fitness to clients ... Ottawa. Fitness on the Go is a Canadian owned ... to helping communities achieve a healthier and fitter lifestyle. ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 In a ... the pharmaceutical giant, Johnson & Johnson, is withdrawing its ... can spread undetected cancer. This important story has ... USA Today (7/31), the AP (7/30), the Pittsburgh Business ... tool is used during uterine procedures to, “slice up ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 3Health News:Fitness on the Go Grows to Ottawa 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 3
... healthcare and human ... ... in,driving peak performance within Health Information Management (HIM),departments, today announced the ... joins Precyse from Pegasus,Communications where she served as Senior Vice President ...
... impact decades later, studies suggest , , WEDNESDAY, April ... high cholesterol levels in midlife are associated with the ... shows. , The apparent link between behavior in the ... from two reports presented Wednesday at the American Academy ...
... Called "Ground-breaking", DUBAI, United Arab Emirates, April ... fall in an 8-week fundraising drive,Dubai Cares announced ... of,its Phase One funding. Dubai Cares has become ... primary education for,children in developing countries., Dubai ...
... Oregon Health & Science University researchers have identified ... , This finding is important because expression of ... as lymphoma and breast cancers, said Charles Lopez, M.D., ... Medicine., The research will be presented at a minisymposium ...
... May is National Skin Cancer,Awareness Month. TOPEX, Inc. ... disease with a low energy or superficial x-ray ... new system provides,an alternative to surgery for treating ... lesions requiring difficult or extensive,surgery with sensitive structures ...
... TO SEX, SOME MEN ARE FROM MARS, OTHERS FROM VENUS ... for Research in Sex, Gender, and Reproduction at Indiana University ... sexual desire and arousal. , Men participating in focus ... such matters as the relationship between erections and desire, the ...
Cached Medicine News:Health News:Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources 2Health News:Smoking, Drinking, Cholesterol May Be Alzheimer's Risk Factors 2Health News:Smoking, Drinking, Cholesterol May Be Alzheimer's Risk Factors 3Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 2Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 3Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 4Health News:An Alternative to Surgery for Treating Skin Cancer 2Health News:An Alternative to Surgery for Treating Skin Cancer 3Health News:IU Health & Wellness: New research findings from the Kinsey Institute 2Health News:IU Health & Wellness: New research findings from the Kinsey Institute 3Health News:IU Health & Wellness: New research findings from the Kinsey Institute 4Health News:IU Health & Wellness: New research findings from the Kinsey Institute 5
(Date:7/31/2014)... VIENNA , July 31, 2014 ... New York results of AFF008, a Phase ... PD01A is the first therapy against the protein alpha-synuclein, a ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) supported ... at the press conference on the impact a disease-modifying therapy ...
(Date:7/31/2014)... Astellas has appointed Moyra Knight ... communications in the Americas region. Knight will report ... president, chief communications officer. In this role, Knight ... brand initiatives and reputation management to achieve Astellas, ... South America . She will also lead ...
(Date:7/31/2014)... Calif., July 31, 2014 Cryoport, Inc. (OTCBB: ... period ended June 30, 2014. Recent ... $0.94 million for the three month period ended June ... , Partnered with DHL to further expand Cryoport,s global ... , Advanced support of Immudex, an immunotherapy and ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8
... IRVINE, Calif., Aug. 11, 2011 ChromaDex Corporation ... provides proprietary, science-based solutions and ingredients to the ... industries, today announced financial results for the second ... calculated in accordance with U.S. Generally Accepted Accounting ...
... 2011 Reportlinker.com announces that a ... available in its catalogue: ... - Global Opportunity Assessment, Competitive ... 2017 ...
Cached Medicine Technology:ChromaDex Announces Financial Results for Second Quarter 2011 2ChromaDex Announces Financial Results for Second Quarter 2011 3ChromaDex Announces Financial Results for Second Quarter 2011 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 2Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 3Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 5Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 6Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 7Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 8Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 9Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 10
Malaria (P. fal.) Ag Rapid Test...
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
Malaria P.f. Rapid Test Device...
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This ...
Medicine Products: